Searched for
GLAND PHARMA NET PROFIT
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...- Leader's Premium: The math behind Jio Platforms' priceJio Platforms' upcoming IPO is priced at a premium, reflecting its market leadership and advanced 4G/5G network. Despite smaller revenues t...
- Hair fall bothering you? Top nutritionist shares 5 simple foods for stronger, healthier hairTired of hair fall? Top nutritionist Sonia Narang reveals five kitchen staples to combat thinning strands. Spinach, ragi flour, black sesam...
- RIL AGM: Reliance Industries shares fall 2% amid Mukesh Ambani's big announcements at 49th AGMReliance Industries shares dipped nearly 2% despite Chairman Mukesh Ambani announcing the approved Jio DRHP for a $4 billion IPO. The compa...
- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- Growth over scale: NSE is priced at a discount to BSENSE's upcoming IPO is set for a discount compared to its peer BSE. This valuation reflects slower growth in NSE's core business. BSE, howev...
- Despite West Asia crisis, net direct tax mopup grows 15% to Rs 5.2 lakh croreIndia's direct tax collections have seen a significant rise of over 14 percent. This growth is driven by strong advance tax payments from c...
- Dhan parent Raise Securities posts Rs 905 crore revenue, profit down 20% in FY26The company had reported net operating income of Rs 795 crore and a profit after tax of Rs 408 crore in FY25. The rating agency attributed ...
- Redington shares rally 10% after Apple CEO Tim Cook says price hikes 'unavoidable' amid AI boomRedington shares surged over 10% after Apple CEO Tim Cook signalled potential price hikes due to rising memory and storage costs driven by ...
- Yes Bank shares jump 16% in 5 days, hit fresh 52-week high. What lies ahead?Yes Bank shares climbed to a fresh 52-week high, extending gains over five sessions and adding Rs 8,662 crore to market value. The rally fo...
- Vishal Mega Mart shares in focus as IPO lock-in expiry frees up shares worth Rs 10,813 crore for tradeVishal Mega Mart shares made a strong market debut, listing with a 41% premium over the IPO price at Rs 110 on BSE in December 2024. Althou...
- Liotech Industries IPO opens for subscription today. Check GMP, price band and other detailsLiotech Industries has fixed the issue price at Rs 321 per share. The IPO is a combination of a fresh issue of 9 lakh shares aggregating Rs...
- Leapfrog Engineering Services IPO: Check GMP, price band, subscription and other detailsThe IPO comprises a fresh issue of 3.46 crore shares aggregating Rs 79.6 crore and an offer for sale of 38.76 lakh shares worth Rs 8.91 cro...
- Tata Sons' chairman N Chandrasekaran declines pay hike amid group concernsTata Sons chairman N. Chandrasekaran will not seek a pay raise for FY26. This decision comes amid group concerns about capital allocation a...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- IPO-bound Zetwerk’s FY26 operating revenue rises to Rs 15,900 crore: CrisilIPO-bound Zetwerk anticipates a rise in operating income to Rs 15,900 crore in FY26, driven by strategic exits from non-core segments and r...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a monthDespite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-we...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...
Load More
